GSK: The Worst Is Finally Over (Rating Upgrade)
GSK's share price rose 6% after settling 93% of Zantac cases, impacting Q3 earnings; forward non-GAAP P/E remains reasonable ...
FTSE 100 movers: GSK surges on Zantac deal; Taylor Wimpey goes ex-div
Shares in GSK surged after the pharmaceuticals company announced a $2.2bn settlement to resolve approximately 80,000 Zantac lawsuits in the US. The company revealed that it had reached agreements with ...
KTEN28m
US, Europe stocks fall on US inflation data
Shares slipped in New York and Europe Thursday as the latest US inflation report strengthened the case for a slower pace of ...
UK borrowing costs hit three-month high amid ‘buyers’ strike’ fears; US inflation dips to 2.4% as jobless claims jump – business live
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
The Globe and Mail22m
Stocks Muted Before the Open With U.S. Inflation Data in Focus
In corporate news, Gsk Plc (GSK.LN) climbed over +5% after the drugmaker agreed to pay up to $2.2 billion to settle U.S. court cases related to its heartburn treatment, Zantac. Italy’s Industrial ...
LIVE: Global stocks fall as US inflation comes in stronger than expected at 2.4%
The FTSE 100 ( ^FTSE) outperformed against European stocks on Thursday amid news that the UK housing market is continuing to ...
The Pharma Letter35m
Cuts for Black Diamond as runway's end nears
Black Diamond Therapeutics (Nasdaq: BDTX) is restructuring to focus on its lead drug, BDTX-1535, aimed at non-small cell lung ...